The thorns of Gleditsia sinensis are a
traditional Oriental medicine used for the treatment of swelling,
suppuration,
carbuncle and
skin diseases. In the present study, we identified a novel molecular mechanism by which an
ethanol extract of Gleditsia sinensis thorns (EEGS) inhibits the growth of the SNU-5 human
gastric cancer cell line. EEGS treatment inhibited cell growth and was associated with G1 phase cell cycle arrest at a concentration of 400 µg/ml (IC50) in SNU-5 cells. Treatment with EEGS also stimulated p21WAF1 expression, which significantly decreased the expression of
cyclins and
cyclin-dependent kinases (CDKs). Further study suggested that
p38 MAP kinase pathways may be involved in the inhibition of cell proliferation through p21WAF1‑dependent G1 phase cell cycle arrest in EEGS-treated cells. In addition, NF-κB and
AP-1 transcription factor binding sites were identified as the cis-elements for
tumor necrosis factor-α (TNF-α)-induced
matrix metalloproteinase-9 (MMP-9) expression in SNU-5 cells, as determined by gel-shift assay. Treatment of cells with EEGS suppressed MMP-9 expression induced by TNF-α via a decrease in the binding activity of both NF-κB and
AP-1 motifs. These data demonstrate that EEGS-mediated inhibition of cell growth appears to involve the activation of
p38 MAP kinase, subsequently leading to the induction of p21WAF1 and the downregulation of cyclin D1/CDK4 and
cyclin E/CDK2 complexes. Moreover, EEGS strongly inhibited TNF-α-induced MMP-9 expression by impeding the
DNA binding activity of NF-κB and
AP-1. Overall, these results provide a potential mechanism for EEGS in the treatment of
gastric cancer.